Literature DB >> 3010842

Antiviral activity of 2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl-5-iodocytosine against human cytomegalovirus in human skin fibroblasts.

J M Colacino, C Lopez.   

Abstract

2'-Deoxy-2'-fluoro-beta-D-arabinofuranosyl-5-iodocytosine (FIAC) was shown to be a selective anti-human cytomegalovirus agent in vitro with a 50% antiviral effective dose of 0.6 microM (J. M. Colacino and C. Lopez, Antimicrob. Agents Chemother. 26:505-508, 1983) and a 50% cell growth inhibitory dose of 8 microM. Antiviral activity was more readily reversed with 10-fold excess thymidine, whereby the 50% effective dose was increased to 11.3 microM. FIAC-induced cytotoxicity was more readily reversed with 10-fold excess of deoxycytidine, whereby the 50% inhibitory dose was increased to greater than 100 microM. Thymidine was unable to reverse completely the antiviral activity of FIAC. Although, the extent of phosphorylation of thymidine, deoxycytidine, and deoxyuridine was 6-, 4-, and 4-fold greater, respectively, in human cytomegalovirus-infected cell lysates than in uninfected cell lysates, the extent of phosphorylation of FIAC was only 1.3-fold greater in human cytomegalovirus-infected cell lysates than in uninfected cell lysates. By comparison, the extent of FIAC phosphorylation was 500 times greater in herpes simplex virus type 1-infected cells than in uninfected cell lysates. Methotrexate was 400 times more effective against human cytomegalovirus replication than it was against herpes simplex virus type 1 replication, indicating that thymidylate synthetase may be important for human cytomegalovirus replication. However, 10 microM FIAC did not inhibit thymidylate synthetase activity in uninfected or virus-infected cells as determined by their metabolism of [6-3H]deoxyuridine in the presence or absence of drug. FIAC at 1 microM suppresses and FIAC at 10 microM completely inhibits human cytomegalovirus DNA replication as indicated by Southern blot analysis. This inhibition was reversible. FIAC incorporation into the DNA of human cytomegalovirus strain AD169-infected cells was stimulated relative to that in nondividing, uninfected cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3010842      PMCID: PMC180228          DOI: 10.1128/AAC.28.2.252

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  22 in total

1.  Human cytomegalovirus. III. Virus-induced DNA polymerase.

Authors:  E S Huang
Journal:  J Virol       Date:  1975-08       Impact factor: 5.103

2.  Properties of herpesvirus-specific thymidine kinase, DNA polymerase and DNase and their implication in the development of specific antiherpes agents.

Authors:  Y C Cheng; P J Hoffmann; M Ostrander; S Grill; S Caradonna; J Tsou; J Y Chen; M R Gallagher; T D Flanagan
Journal:  Adv Ophthalmol       Date:  1979

3.  Nucleosides. 110. Synthesis and antiherpes virus activity of some 2'-fluoro-2'-deoxyarabinofuranosylpyrimidine nucleosides.

Authors:  K A Watanabe; U Reichman; K Hirota; C Lopez; J J Fox
Journal:  J Med Chem       Date:  1979-01       Impact factor: 7.446

4.  Gel electrophoresis and isoelectric focusing of mitochondrial and viral-induced thymidine kinases.

Authors:  S Kit; W C Leung; D Trkula; G Jorgensen
Journal:  Int J Cancer       Date:  1974-02-15       Impact factor: 7.396

5.  Thymidine-kinase in cytomegalovirus infected cells.

Authors:  V Závada; V Erban; D Rezácová; V Vonka
Journal:  Arch Virol       Date:  1976       Impact factor: 2.574

6.  In vitro metabolism of 1-beta-D-arabinofuranosylcytosine and 1-beta-2'-fluoroarabino-5-iodocytosine in normal and herpes simplex type 1 virus-infected cells.

Authors:  W Kreis; L Damin; J Colacino; C Lopez
Journal:  Biochem Pharmacol       Date:  1982-03-01       Impact factor: 5.858

7.  Metabolism of acyclovir in virus-infected and uninfected cells.

Authors:  P A Furman; P de Miranda; M H St Clair; G B Elion
Journal:  Antimicrob Agents Chemother       Date:  1981-10       Impact factor: 5.191

8.  Efficacy and selectivity of some nucleoside analogs as anti-human cytomegalovirus agents.

Authors:  J M Colacino; C Lopez
Journal:  Antimicrob Agents Chemother       Date:  1983-10       Impact factor: 5.191

9.  Deoxyribopyrimidine triphosphatase activity specific for cells infected with herpes simplex virus type 1.

Authors:  F Wohlrab; B Francke
Journal:  Proc Natl Acad Sci U S A       Date:  1980-04       Impact factor: 11.205

10.  Anti-herpesvirus activity of the acyclic nucleoside 9-(1,3-dihydroxy-2-propoxymethyl)guanine.

Authors:  D F Smee; J C Martin; J P Verheyden; T R Matthews
Journal:  Antimicrob Agents Chemother       Date:  1983-05       Impact factor: 5.191

View more
  2 in total

1.  Ganciclovir-resistant cytomegalovirus clinical isolates: mode of resistance to ganciclovir.

Authors:  S C Stanat; J E Reardon; A Erice; M C Jordan; W L Drew; K K Biron
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

2.  (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl)cytosine, a potent and selective inhibitor of human cytomegalovirus replication.

Authors:  R Snoeck; T Sakuma; E De Clercq; I Rosenberg; A Holy
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.